Related Experiment Video
Updated: Nov 3, 2025

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
Published on: November 2, 2020
Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies
Riccardo Vio1, Annalisa Angelini1, Cristina Basso1
1Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, 35128 Padova, Italy.
Insights
Hypertrophic cardiomyopathy (HCM) and restrictive cardiomyopathy (RCM) share genetic roots and diastolic dysfunction. Familial RCM may be part of HCM
Area of Science:
- Cardiology
- Genetics
- Pathophysiology
Background:
- Hypertrophic cardiomyopathy (HCM) and primary restrictive cardiomyopathy (RCM) share sarcomeric gene variants and diastolic dysfunction.
- Familial RCM cases may represent a phenotypic spectrum of HCM, challenging distinct genetic classifications.
- Infiltrative and storage diseases can mimic HCM or RCM phenotypes.
Purpose of the Study:
- To explore the hypothesis that familial primary RCM is part of the HCM phenotypic spectrum.
- To highlight the importance of accurate etiological diagnosis for sarcomeric cardiomyopathies and phenocopies.
Main Methods:
- Review of existing literature and clinical observations regarding HCM and RCM.
- Analysis of genetic backgrounds and pathophysiological mechanisms.
- Comparison of clinical presentations and diagnostic criteria.
Main Results:
- HCM and primary RCM share significant genetic and pathophysiological similarities.
- A distinct pathophysiological profile of HCM with restrictive physiology supports a unified spectrum hypothesis.
- Phenotypic overlap exists with infiltrative and storage diseases, complicating diagnosis.
Conclusions:
- Familial RCM may not be a distinct genetic cardiomyopathy but rather a manifestation of HCM.
- Accurate etiological diagnosis is crucial for guiding family screening and therapeutic strategies.
- Distinguishing between HCM, primary RCM, and phenocopies is essential for patient management.
Abstract:
Hypertrophic cardiomyopathy (HCM) and primary restrictive cardiomyopathy (RCM) have a similar genetic background as they are both caused mainly by variants in sarcomeric genes. These "sarcomeric cardiomyopathies" also share diastolic dysfunction as the prevalent pathophysiological mechanism. Starting from the observation that patients with HCM and primary RCM may coexist in the same family, a characteristic pathophysiological profile of HCM with restrictive physiology has been recently described and supports the hypothesis that familiar forms of primary RCM may represent a part of the phenotypic spectrum of HCM rather than a different genetic cardiomyopathy. To further complicate this scenario some infiltrative (amyloidosis) and storage diseases (Fabry disease and glycogen storage diseases) may show either a hypertrophic or restrictive phenotype according to left ventricular wall thickness and filling pattern. Establishing a correct etiological diagnosis among HCM, primary RCM, and hypertrophic or restrictive phenocopies is of paramount importance for cascade family screening and therapy.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...

